Filana Therapeutics Inc stock is traded at $0.4316, with a volume of 351,804. It is down -4.30% in the last 24 hours and down -50.67% over the past month. Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Previous Close:
$0.451
Open:
$0.4601
24h Volume:
351,804
Relative Volume:
0.81
Market Cap:
$20.85M
Revenue:
-
Net Income/Loss:
-$77.90M
P/E Ratio:
-
EPS:
-$1.61
Net Cash Flow:
-$30.38M
1W Performance:
-30.61%
1M Performance:
-50.67%
6M Performance:
-70.03%
1Y Performance:
0.00%
1-Day Range:
$0.4288$0.4698
1-Week Range:
$0.4288$0.63
52-Week Range:
$0.4288$2.27
Filana Therapeutics Inc Stock (FLNA) Company Profile
Name
Filana Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
512-501-2444Address
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS